drugset / Trial / NCT00880490
Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of inhaled PT005 compared to placebo and Formoterol Fumarate (Foradil Aerolizer) in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2008-11
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PT005 | Unknown | 2.4 ug | Inhaled |
| Subject | PT005 | Unknown | 4.8 ug | Inhaled |
| Subject | PT005 | Unknown | 9.6 ug | Inhaled |
| Subject | PT005 | Unknown | 12 ug | Inhaled |